| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disulfiram is a synthetic small-molecule drug best known for its use in the treatment of chronic alcohol use disorder. It is a thiuram disulfide compound with the chemical formula C₁₀H₂₀N₂S₄ and acts primarily as an aldehyde dehydrogenase (ALDH) inhibitor.
Main Actions: -Potent copper-dependent pro-oxidant -Targets ALDH⁺ cancer stem cells -Strong clinical repurposing interest Key pathways -Cu-mediated redox cycling -Proteasome inhibition -Mitochondrial ROS Chemo relevance -Often synergistic -Highly mechanism-dependent
|
| Source: |
| Type: |
| Kelch-like ECH-associated protein 1 (Keap1) is a key regulator of the transcription factor Nrf2. -In several tumor types, loss of Keap1 function (either due to gene mutations or low protein expression) results in unrestrained Nrf2 activity. • Persistent Nrf2 activation is thought to: - Provide tumor cells with enhanced protection against oxidative stress. - Contribute to chemoresistance and radioresistance. - Promote metabolic reprogramming that fuels tumor growth. • Thus, in many cancers, altered Keap1 status can serve as an indicator of poor prognosis and has been investigated as a potential target for therapeutic intervention. |
| 5008- | DSF, | Cu, | Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis |
| - | in-vitro, | HCC, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:387 Target#:1174 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid